yingweiwo

Didocosahexaenoin (docosahexaenoic acid diglyceride)

Cat No.:V35044 Purity: ≥98%
Didocosahexaenoin is an omega-3 analogue that is a diglyceride of DHA and can be synthesized from DHA triglyceride.
Didocosahexaenoin (docosahexaenoic acid diglyceride)
Didocosahexaenoin (docosahexaenoic acid diglyceride) Chemical Structure CAS No.: 124538-05-2
Product category: Apoptosis
This product is for research use only, not for human use. We do not sell to patients.
Size Price Stock Qty
1mg
Other Sizes
Official Supplier of:
Alternate Text
Alternate Text
Alternate Text
Alternate Text
Alternate Text
Alternate Text
Alternate Text
Alternate Text
Alternate Text
Alternate Text
Alternate Text
Alternate Text
Alternate Text
Alternate Text
Alternate Text
Alternate Text
Alternate Text
Alternate Text
Alternate Text
Alternate Text
Alternate Text
Alternate Text
Alternate Text
Alternate Text
Alternate Text
Alternate Text
Alternate Text
Alternate Text
Alternate Text
Alternate Text
Alternate Text
Alternate Text

 

  • Business Relationship with 5000+ Clients Globally
  • Major Universities, Research Institutions, Biotech & Pharma
  • Citations by Top Journals: Nature, Cell, Science, etc.
Top Publications Citing lnvivochem Products
Product Description
Didocosahexaenoin is an omega-3 analogue that is a diglyceride of DHA and can be synthesized from DHA triglyceride. Didocosahexaenoin causes a significant loss of mitochondrial membrane potential and induces ROS production. Didocosahexaenoin causes apoptosis. Didocosahexaenoin induces greater cytotoxic effect than DHA in human prostate cancer cells.
Didocosahexaenoin (docosahexaenoic acid diglyceride) (CAS#: 124538-05-2) is a diacylglycerol containing docosahexaenoic acid (DHA) at two positions. It has the molecular formula C47H68O5 and a molecular weight of 713.04 g/mol. It is an omega-3 analogue and can be synthesized from DHA triglyceride. As a diglyceride of DHA, it is a source of DHA, which is an essential fatty acid with important roles in human health, particularly in brain and eye development. In research, it has been investigated for its potential effects on reactive oxygen species (ROS) and apoptosis. It is a lipophilic compound and is typically formulated in organic solvents or lipid emulsions for in vitro studies.
Biological Activity I Assay Protocols (From Reference)
Targets
The primary biological target of didocosahexaenoin is not a specific protein or enzyme. It is a lipid molecule that can be incorporated into cell membranes and modulate their properties. Its effects are thought to be mediated through its role as a source of DHA, which can influence various signaling pathways. It has been suggested to affect the production of reactive oxygen species (ROS) and to modulate apoptotic pathways. However, the exact molecular targets and mechanisms of action are not well-defined. Its biological effects are likely due to the release of DHA upon hydrolysis, which can then be metabolized into bioactive lipid mediators.
ln Vitro
In PC3 cells, docosahexaenoic acid diglyceride (10–50 μM; 96 hours) causes apoptosis [1]. In human prostate cells, docosahexaenoic acid diglyceride (1 nM-100 μM; 96 hours) causes dose-dependent cytotoxicity [1]. The loss of mitochondrial membrane potential is significantly increased by docosahexaenoic acid diglyceride (30, 50 μM; 24 hours) [1].
In vitro studies have investigated the effects of didocosahexaenoin on cells. It has been shown to modulate the levels of reactive oxygen species (ROS) and to influence apoptosis. The specific effects depend on the cell type and the concentration used. As a DHA-containing lipid, it may also affect cell membrane fluidity and the function of membrane proteins. Its ability to act as a source of DHA suggests that it could have similar biological activities to free DHA, but the kinetics and efficiency of release may differ. Further in vitro studies are needed to fully characterize its biological activity.
ln Vivo
Information regarding the in vivo activity of didocosahexaenoin in animal models is limited. Its biological activity has been primarily characterized through in vitro assays. As a source of DHA, it may have beneficial effects in vivo, but these have not been extensively studied. DHA itself is known to have anti-inflammatory and neuroprotective effects, but whether didocosahexaenoin can effectively deliver DHA in vivo and produce these effects is not clear. Further studies are required to determine its pharmacokinetic properties and its potential efficacy in animal models of disease.
Enzyme Assay
The non-cellular enzyme or receptor binding assay for didocosahexaenoin is not applicable. It is not a ligand that binds to a specific enzyme or receptor. Its biological effects are mediated through its incorporation into cell membranes and its role as a source of DHA. Its interaction with cells can be studied using lipid binding assays or by measuring its incorporation into cellular membranes using mass spectrometry. However, these are not "binding assays" in the traditional pharmacological sense. Its activity is more related to its metabolism and physical properties.
Cell Assay
Apoptosis Analysis[1]
Cell Types: PC3 cells
Tested Concentrations: 10, 20, 30, 40, 50 μM
Incubation Duration: 24, 48 hrs (hours)
Experimental Results: Caused elevated levels of early apoptotic cells. Dramatically increased the level of activated caspase 3/7 for 6 h at 30 and 50 μM.
Cell Cytotoxicity Assay[1]
Cell Types: PC3, DU145, A2780 and A2780-CP70 carcinoma cells and MCF-7 and LNCaP cells
Tested Concentrations: 1 nM-100 μM
Incubation Duration: 96 hrs (hours)
Experimental Results: Induced dose-dependent cytotoxicity with the strongest toxicity under 10.0 μM on DU145 and PC3 cells, A2780 and A2780-CP70 with IC50 of 3.20 and 3.82 μM, 4.6, 5.53 μM, respectively.
The in vitro cellular assay for didocosahexaenoin involves treating cells with various concentrations of the compound. The effect on ROS production is measured using a fluorescent probe such as DCFH-DA. Apoptosis is evaluated using flow cytometry with Annexin V/PI staining or by measuring caspase-3/7 activity. The incorporation of DHA into cellular membranes can be assessed by lipid extraction and gas chromatography-mass spectrometry (GC-MS). Cell viability is assessed using standard assays like MTT. These assays are used to study the biological effects of this DHA diglyceride on cells.
Animal Protocol
The in vivo animal experiment workflow for didocosahexaenoin has not been well-established. If an animal study were to be designed, it would likely involve the use of a mouse model. The compound would be administered via oral gavage or intraperitoneal injection, likely formulated in a lipid vehicle. The outcomes measured would depend on the specific research question, such as the effect on inflammation, oxidative stress, or cognitive function. The levels of DHA and its metabolites in tissues would be quantified by GC-MS to assess the bioavailability and metabolism of the compound. These studies would provide insights into its potential in vivo effects.
References

[1]. Investigation of the cytotoxicity induced by didocosahexaenoin, an omega 3 derivative, in human prostate carcinoma cell lines. Curr Res Pharmacol Drug Discov. 2022 Jan 19;3:100085.

These protocols are for reference only. InvivoChem does not independently validate these methods.
Physicochemical Properties
Molecular Formula
C25H40O5
Molecular Weight
420.58
Exact Mass
712.506
CAS #
124538-05-2
PubChem CID
53389484
Appearance
Typically exists as solid at room temperature
Density
1.0±0.1 g/cm3
Boiling Point
748.5±60.0 °C at 760 mmHg
Flash Point
204.8±26.4 °C
Vapour Pressure
0.0±5.7 mmHg at 25°C
Index of Refraction
1.528
LogP
13.59
tPSA
72.8
Hydrogen Bond Donor Count
1
Hydrogen Bond Acceptor Count
5
Rotatable Bond Count
34
Heavy Atom Count
52
Complexity
1120
Defined Atom Stereocenter Count
0
SMILES
O(C(CC/C=C\C/C=C\C/C=C\C/C=C\C/C=C\C/C=C\CC)=O)CC(COC(CC/C=C\C/C=C\C/C=C\C/C=C\C/C=C\C/C=C\CC)=O)O
InChi Key
MXYFTPKXCFFQRG-GZSOIYOPSA-N
InChi Code
InChI=1S/C47H68O5/c1-3-5-7-9-11-13-15-17-19-21-23-25-27-29-31-33-35-37-39-41-46(49)51-43-45(48)44-52-47(50)42-40-38-36-34-32-30-28-26-24-22-20-18-16-14-12-10-8-6-4-2/h5-8,11-14,17-20,23-26,29-32,35-38,45,48H,3-4,9-10,15-16,21-22,27-28,33-34,39-44H2,1-2H3/b7-5-,8-6-,13-11-,14-12-,19-17-,20-18-,25-23-,26-24-,31-29-,32-30-,37-35-,38-36-
Chemical Name
[3-[(4Z,7Z,10Z,13Z,16Z,19Z)-docosa-4,7,10,13,16,19-hexaenoyl]oxy-2-hydroxypropyl] (4Z,7Z,10Z,13Z,16Z,19Z)-docosa-4,7,10,13,16,19-hexaenoate
HS Tariff Code
2934.99.9001
Storage

Powder      -20°C    3 years

                     4°C     2 years

In solvent   -80°C    6 months

                  -20°C    1 month

Shipping Condition
Room temperature (This product is stable at ambient temperature for a few days during ordinary shipping and time spent in Customs)
Solubility Data
Solubility (In Vitro)
May dissolve in DMSO (in most cases), if not, try other solvents such as H2O, Ethanol, or DMF with a minute amount of products to avoid loss of samples
Solubility (In Vivo)
Note: Listed below are some common formulations that may be used to formulate products with low water solubility (e.g. < 1 mg/mL), you may test these formulations using a minute amount of products to avoid loss of samples.

Injection Formulations
(e.g. IP/IV/IM/SC)
Injection Formulation 1: DMSO : Tween 80: Saline = 10 : 5 : 85 (i.e. 100 μL DMSO stock solution → 50 μL Tween 80 → 850 μL Saline)
*Preparation of saline: Dissolve 0.9 g of sodium chloride in 100 mL ddH ₂ O to obtain a clear solution.
Injection Formulation 2: DMSO : PEG300 :Tween 80 : Saline = 10 : 40 : 5 : 45 (i.e. 100 μL DMSO → 400 μLPEG300 → 50 μL Tween 80 → 450 μL Saline)
Injection Formulation 3: DMSO : Corn oil = 10 : 90 (i.e. 100 μL DMSO → 900 μL Corn oil)
Example: Take the Injection Formulation 3 (DMSO : Corn oil = 10 : 90) as an example, if 1 mL of 2.5 mg/mL working solution is to be prepared, you can take 100 μL 25 mg/mL DMSO stock solution and add to 900 μL corn oil, mix well to obtain a clear or suspension solution (2.5 mg/mL, ready for use in animals).
View More

Injection Formulation 4: DMSO : 20% SBE-β-CD in saline = 10 : 90 [i.e. 100 μL DMSO → 900 μL (20% SBE-β-CD in saline)]
*Preparation of 20% SBE-β-CD in Saline (4°C,1 week): Dissolve 2 g SBE-β-CD in 10 mL saline to obtain a clear solution.
Injection Formulation 5: 2-Hydroxypropyl-β-cyclodextrin : Saline = 50 : 50 (i.e. 500 μL 2-Hydroxypropyl-β-cyclodextrin → 500 μL Saline)
Injection Formulation 6: DMSO : PEG300 : castor oil : Saline = 5 : 10 : 20 : 65 (i.e. 50 μL DMSO → 100 μLPEG300 → 200 μL castor oil → 650 μL Saline)
Injection Formulation 7: Ethanol : Cremophor : Saline = 10: 10 : 80 (i.e. 100 μL Ethanol → 100 μL Cremophor → 800 μL Saline)
Injection Formulation 8: Dissolve in Cremophor/Ethanol (50 : 50), then diluted by Saline
Injection Formulation 9: EtOH : Corn oil = 10 : 90 (i.e. 100 μL EtOH → 900 μL Corn oil)
Injection Formulation 10: EtOH : PEG300:Tween 80 : Saline = 10 : 40 : 5 : 45 (i.e. 100 μL EtOH → 400 μLPEG300 → 50 μL Tween 80 → 450 μL Saline)


Oral Formulations
Oral Formulation 1: Suspend in 0.5% CMC Na (carboxymethylcellulose sodium)
Oral Formulation 2: Suspend in 0.5% Carboxymethyl cellulose
Example: Take the Oral Formulation 1 (Suspend in 0.5% CMC Na) as an example, if 100 mL of 2.5 mg/mL working solution is to be prepared, you can first prepare 0.5% CMC Na solution by measuring 0.5 g CMC Na and dissolve it in 100 mL ddH2O to obtain a clear solution; then add 250 mg of the product to 100 mL 0.5% CMC Na solution, to make the suspension solution (2.5 mg/mL, ready for use in animals).
View More

Oral Formulation 3: Dissolved in PEG400
Oral Formulation 4: Suspend in 0.2% Carboxymethyl cellulose
Oral Formulation 5: Dissolve in 0.25% Tween 80 and 0.5% Carboxymethyl cellulose
Oral Formulation 6: Mixing with food powders


Note: Please be aware that the above formulations are for reference only. InvivoChem strongly recommends customers to read literature methods/protocols carefully before determining which formulation you should use for in vivo studies, as different compounds have different solubility properties and have to be formulated differently.

 (Please use freshly prepared in vivo formulations for optimal results.)
Preparing Stock Solutions 1 mg 5 mg 10 mg
1 mM 2.3777 mL 11.8883 mL 23.7767 mL
5 mM 0.4755 mL 2.3777 mL 4.7553 mL
10 mM 0.2378 mL 1.1888 mL 2.3777 mL

*Note: Please select an appropriate solvent for the preparation of stock solution based on your experiment needs. For most products, DMSO can be used for preparing stock solutions (e.g. 5 mM, 10 mM, or 20 mM concentration); some products with high aqueous solubility may be dissolved in water directly. Solubility information is available at the above Solubility Data section. Once the stock solution is prepared, aliquot it to routine usage volumes and store at -20°C or -80°C. Avoid repeated freeze and thaw cycles.

Calculator

Molarity Calculator allows you to calculate the mass, volume, and/or concentration required for a solution, as detailed below:

  • Calculate the Mass of a compound required to prepare a solution of known volume and concentration
  • Calculate the Volume of solution required to dissolve a compound of known mass to a desired concentration
  • Calculate the Concentration of a solution resulting from a known mass of compound in a specific volume
An example of molarity calculation using the molarity calculator is shown below:
What is the mass of compound required to make a 10 mM stock solution in 5 ml of DMSO given that the molecular weight of the compound is 350.26 g/mol?
  • Enter 350.26 in the Molecular Weight (MW) box
  • Enter 10 in the Concentration box and choose the correct unit (mM)
  • Enter 5 in the Volume box and choose the correct unit (mL)
  • Click the “Calculate” button
  • The answer of 17.513 mg appears in the Mass box. In a similar way, you may calculate the volume and concentration.

Dilution Calculator allows you to calculate how to dilute a stock solution of known concentrations. For example, you may Enter C1, C2 & V2 to calculate V1, as detailed below:

What volume of a given 10 mM stock solution is required to make 25 ml of a 25 μM solution?
Using the equation C1V1 = C2V2, where C1=10 mM, C2=25 μM, V2=25 ml and V1 is the unknown:
  • Enter 10 into the Concentration (Start) box and choose the correct unit (mM)
  • Enter 25 into the Concentration (End) box and select the correct unit (mM)
  • Enter 25 into the Volume (End) box and choose the correct unit (mL)
  • Click the “Calculate” button
  • The answer of 62.5 μL (0.1 ml) appears in the Volume (Start) box
g/mol

Molecular Weight Calculator allows you to calculate the molar mass and elemental composition of a compound, as detailed below:

Note: Chemical formula is case sensitive: C12H18N3O4  c12h18n3o4
Instructions to calculate molar mass (molecular weight) of a chemical compound:
  • To calculate molar mass of a chemical compound, please enter the chemical/molecular formula and click the “Calculate’ button.
Definitions of molecular mass, molecular weight, molar mass and molar weight:
  • Molecular mass (or molecular weight) is the mass of one molecule of a substance and is expressed in the unified atomic mass units (u). (1 u is equal to 1/12 the mass of one atom of carbon-12)
  • Molar mass (molar weight) is the mass of one mole of a substance and is expressed in g/mol.
/

Reconstitution Calculator allows you to calculate the volume of solvent required to reconstitute your vial.

  • Enter the mass of the reagent and the desired reconstitution concentration as well as the correct units
  • Click the “Calculate” button
  • The answer appears in the Volume (to add to vial) box
In vivo Formulation Calculator (Clear solution)
Step 1: Enter information below (Recommended: An additional animal to make allowance for loss during the experiment)
Step 2: Enter in vivo formulation (This is only a calculator, not the exact formulation for a specific product. Please contact us first if there is no in vivo formulation in the solubility section.)
+
+
+

Calculation results

Working concentration: mg/mL;

Method for preparing DMSO stock solution: mg drug pre-dissolved in μL DMSO (stock solution concentration mg/mL). Please contact us first if the concentration exceeds the DMSO solubility of the batch of drug.

Method for preparing in vivo formulation::Take μL DMSO stock solution, next add μL PEG300, mix and clarify, next addμL Tween 80, mix and clarify, next add μL ddH2O,mix and clarify.

(1) Please be sure that the solution is clear before the addition of next solvent. Dissolution methods like vortex, ultrasound or warming and heat may be used to aid dissolving.
             (2) Be sure to add the solvent(s) in order.

Contact Us